| Document Date: 2012-09-11 17:00:17
Open Document File Size: 92,63 KBShare Result on Facebook
City Williston / / Company Lundbeck / Pediatric AntipsychoticTrend Monitoring Group / Allergan / MedMetrics Health Partners / MedImmune / HP / Abbott Labs / Endo Pharmaceuticals / DUR Board Minutes / / Event Product Issues / FDA Phase / Natural Disaster / Product Recall / / Facility Pharmacy Newsletter / p.m.* HP Building / / IndustryTerm treatment of multiple sclerosis / / MedicalCondition progressive multifocal leukoencephalopathy / multiple sclerosis / serious brain infection / Cystic Fibrosis / ADHD / cancer / Crohn’s disease / diabetes / Hepatic Encephalopathy / allergy / atrial fibrillation / hereditary angioedema agents / / Organization Attorney General’s Office / FDA / Next DUR Board / Access Pharmacy Benefit Management Program DUR Board / / Person Mark Pasanen / Boehringer Ingelheim Michael Scovner / Kim Ladue / Michelle Sirois / Lynne Vezina / Jim Pitt / Thomas Currier / Janssen Kate Whelley McCabe / Andy Miller / Diane Neal / Sommer Zarbock / Amanda Kennedy / Halle Sobel / Gary Starecheski / Jai Persico / Session / Stacey Baker / Boehringer Ingelheim Wendy Morgan / Joseph Lasek / Heather Thompson / Nancy Hogue / John Donovan / Michael Scovner / Jennifer Egelhof / Kate Whelley McCabe / Preeti Kanojia / Larry Rees / Christine Dube / James Kokoszyna / David Downey / Jaskanwar Batra / Michael Farber / Chris Michaels / Elan Heather Thompson / Melissa Guiles / Jeanne Greenblatt / / Position Director Update / Medical Director / Assistant Attorney General / Executive / Chair / / Product Janumet / morphine sulfate / Opana / Oral Tablet / ibuprofen / famotidine / Aliskiren-Market / Strattera / Xifaxan / fentanyl / Januvia / lactulose / Tysabri / Opana® ER / G551D / Duexis® / response / / ProvinceOrState Vermont / /
SocialTag |
Department of Vermont Health Access Pharmacy Benefit Management Program DUR Board Meeting Minutes: [removed]Board Members: Present: Michael Scovner, MD, Chair